肝胆膵外科 論文(2018年)

【英文論文】
 原著論文

  1. . Kato Y, Okamura Y,Sugiura T,Ito T,Yamamoto Y,Ashida R,Uesaka K. The impact of serosal invasion on prognosis after curative hepatectomy for hepatocellular carcinoma: invasion to adjacent organs and rupture of tumor were crucial tumor-related prognostic factors needed for survival. Dig Surg. 2018;35:155-63.

  2. Ashida R,Okamura Y,Ohshima K,Kakuda Y,Uesaka K,Sugiura T,Ito T,Yamamoto Y,Sugino T,Urakami K,Kusuhara M,Yamaguchi K. The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma. Oncotarget. 2018;9:22058-68.

  3. Watanabe N, Yamamoto Y,Sugiura T,Okamura Y,Ito T,Ashida R,Aramaki T, Uesaka k. A predictive scoring system for insufficient liver hypertrophy after preoperative portal vein embolization. Surgery. 2018;163:1014-9.

  4. Kohga A, Yamamoto Y,Sugiura T,Okamura Y,Ito T,Ashida R,Aramaki T, Sasaki K, Uesaka K. Bile duct angulation and tumor vascularity are useful radiographic features for differentiating pancreatic head cancer and intrapancreatic bile duct cancer. Surgery Today. 2018;48:673-9.

  5. Ito T,SUgiura T,Okamura Y,Yamamoto Y,Ashida R,Aramaki T, Endo M, Matsubayashi H, Ishiwatari H, Uesaka K. Late benign biliary complications after pancreatoduodenectomy. Surgery. 2018;163:1295-300.

  6. Sano S,Yamamoto Y,Sugiura T,Okamura Y,Ito T,Ashida R,Ohgi K,Aramaki T,Nakanuma Y,Uesaka K. The radiological differentiation of hypervascular intrahepatic cholangiocarcinoma from hepatocellular carcinoma with a focus on the CT value on multi-phase enhanced CT. Anticancer Research. 2018;38:5505-12.

  7. Kato Y,Okamura Y,Omae K,Sugiura T,Ito T,Yamamoto Y,Ashida R,Sato R,Aramaki T,Uesaka K. Propensity score-matched comparison of non-anatomical resection and radiofrequency ablation for hepatocellular carcinoma in patients with up to three tumors, each measuring up to 3 cm in diameter. BJS Open. 2018;2:213-9.

  8. Okamura Y,Sugiura T,Ito T,Yamamoto Y,Ashida R,Uesaka K. The short-and long-term outcomes in elderly patients with hepatocellular carcinoma after curative surgery: A case-controlled study with propensity score matching. Eur Surg Res. 2018;59:380-90.

  9. Okamura Y,Sugiura T,Ito T,Yamamoto Y,Ashida R,Uesaka K. The impact of the hepatitis B core antibody status on recurrence in patients with non-B non-C hetatocellular carcinoma after curative surgery. Dig Surg. 2018;35:243-51.

  10. Yamamoto Y.Ashida R,Ohgi K,Sugiura T,Okamura Y,Ito T,Kato Y,Yamada M,Uesaka K. Combined antrectomy reduces the incidence of delayed gastric emptying after pancreatoduodenectomy. Dig Surg. 2018;35:121-30.

  11. Kiuchi R,Mizuno T,Okamura Y,Sugiura T,Kanemoto H,Uesaka K. Circumportal pancreas - a hazardous anomaly in pancreatic surgery. HPB. 2018;20:385-91.

  12. Okamura Y,Sugiura T,Ito T,Yamamoto Y,Ashida R,Aramaki T,Uesaka K. The predictors of microscopic vessel invasion differ between primary hepatocellular carcinoma and hepatocellular carcinoma with a treatment history. World J Surg. 2018;42:3694-704.

  13. Yamamoto Y,Sugiura T,Todaka A,Okamura Y,Ito T,Ashida R,Kakuda Y,Nakanuma Y,Uesaka K. Surgical indication for advanced intrahepatic cholangiocarcinoma according to the optimal preoperative carbohydrate antigen 19-9 cutoff value. World J Surg. 2018;42:3331-40.

  14. Okamura Y,Sano S,Sugiura T,Ito T,Yamamoto Y,Ashida R,Ishiwatari H,Matsubayashi H,Sasaki K,Uesaka K. The 2012 international consensus guidelines of intraductal papillary mucinous neoplasms of the pancreas (Fukuoka Criteria) predict the malignant potential, even in actual clinical situations. Pancreas. 2018;47:285-90.

  15. Yamada M, Sugiura T,Okamura Y,Ito T,Yamamoto Y,Ashida R,Sasaki K, Nagino M, Uesaka K. Microscopic venous invasion in pancreatic cancer. Ann Surg Oncol. 2018;25:1043-51.

 症例報告

  1. Miyata T,Yamamoto Y,Sugiura T,Okamura Y,Ito T,Ashida R,Uemura S,Kato Y,Ohgi K,Uchida T,Sano S,Nakagawa M,Uesaka K. Pancreaticoduodenectomy with hepatic arterial revascularization for pancreatic head cancer with stenosis of the celiac axis due to compression by the median arcuate ligament: a case report. Journal of Surgical Case Reports. 2018;1:1-4.

  2. Tamura S,Yamamoto Y,Okamura Y,Sugiura T,Ito T,Ashida R,Ohgi K,Watanabe N,Sasaki K,Sugino T,Uesaka K. A case of duodenal hemorrhage due to arteriovenous malformation around a serous cystic neoplasm. Surgical Case Reports. 2018;4:140.

  3. Miyata T, Yamamoto Y,Sugiura T,Okamura Y,Ito T,Ashida R,Uemura S, Kato Y, Ohgi K,Kohga A, Uchida T, Sano S, Uesaka K. Combined resection of the transpancreatic common hepatic artery preserving the gastric arterial arcade without arterial reconstruction in hepatopancreatoduodenectomy: a case report. Surgical Case Reports. 2018;4:64.

【和文論文】
解説その他

  1. 杉浦禎一,上坂克彦. 膵癌の術後補助療法は推奨されるか―推奨されるとすれば何が望ましいか―. 肝・胆・膵. 2018;76:407-10.

  2. 蘆田良,杉浦禎一,岡村行泰,伊藤貴明,山本有祐,上坂克彦. 止血 開腹手術. 消化器外科. 2018;41:451-6.

  3. 蘆田良,杉浦禎一,岡村行泰,伊藤貴明,山本有祐,大木克久,上坂克彦. Acute on chronicー慢性病態の急性増悪ー IgG4関連硬化性胆管炎の急速進行. 肝・胆・膵. 2018;76:1131-6.

  4. 伊藤貴明,杉浦禎一,岡村行泰,山本有祐,蘆田良,坂東悦郎,塩見明生,寺島雅典,上坂克彦. イラストで学ぶ解剖学的変異―外科手術アトラス Ⅵ.肝胆膵外科領域 8. 膵管非癒合. 外科. 2018;80:555-9.

  5. 岡村行泰,杉浦禎一,伊藤貴明,山本有祐,蘆田良,上坂克彦. Ⅴ-2 膵液廔に対する予防法と現状. 手術. 2018;72:545-51.

肝・胆・膵外科

肝・胆・膵外科